Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.

Can low-dose naltrexone relieve pain?

The Seattle times
12 Jan 2022
https://www.seattletimes.com/life/wellness/can-low-dose-naltrexone-relieve-pain/

At low doses (1 to 4.5 mg) it is prescribed to ease the pain and inflammation associated with conditions such as fibromyalgia, chronic pain syndrome, multiple sclerosis and Crohn’s disease

Low-dose Naltrexone for atopic dermatitis?

National Eczema Association
11 April 2019
https://nationaleczema.org/naltrexone/

Bron Webster interviews Linda Elsegood (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Shares her Multiple Sclerosis and Low Dose Naltrexone (LDN) Journey

Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology in female mice with experimental autoimmune encephalomyelitis

J Neurosci Res
25 November 2021
https://pubmed.ncbi.nlm.nih.gov/34821408/

LDN in Clinical Practice - Andrew McCall, MB, ChB, DFM (2021 Conference) (LDN, low dose naltrexone)

Multiple Sclerosis - The role of combination therapy of LDN and Testosterone ... - Harpal Bains, MD (2021 Conference) (LDN, low dose naltrexone)

Lyme Disease - Darin Ingels, ND (2021 Conference) (LDN, low dose naltrexone)

Endogenous opioids modulate inflammation in the animal model of Multiple Sclerosis - Chirag Patel, MD (2021 Conference) (LDN, low dose naltrexone)